Akebia Therapeutics's total assets for Q3 2025 were $364.15M, an increase of 5.37% from the previous quarter. AKBA total liabilities were $322.56M for the fiscal quarter, a 1.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.